Melissa Doering
Nurse Practitioner · Mount Pleasant, SCNPI 1083229439
Payments from drug & device makers
Across 123 payments — averaging $19.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- IBSA Pharma Inc.$596
- Amgen$473
- Novo Nordisk$280
- Amneal Pharmaceuticals LLC$248
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$190
- Lilly USA, LLC$94
- plus $497 from 11 others
What the payments were for
- Food & beverage$2,378100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| IBSA Pharma Inc. | 32 | $596 |
| Amgen(2 entities) | 23 | $473 |
| Novo Nordisk | 14 | $280 |
| Amneal Pharmaceuticals LLC | 14 | $248 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $190 |
| Lilly USA, LLC | 5 | $94 |
| Ascendis Pharma Endocrinology Inc | 5 | $90 |
| Virtus Pharmaceuticals LLC | 4 | $89 |
| AbbVie | 3 | $59 |
| Madrigal Pharmaceuticals | 3 | $58 |
| Acella Pharmaceuticals, LLC | 2 | $45 |
| Corcept Therapeutics | 2 | $36 |
| Eisai Inc. | 1 | $32 |
| Currax Pharmaceuticals LLC | 2 | $26 |
| Ardelyx, Inc. | 1 | $22 |
| Blueprint Medicines Corporation | 1 | $22 |
| Bayer | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$104
How this compares
$2,378 in reported general payments places this provider in the 85th percentile of 1,346 nurse practitioner providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 22 | $19,867 |
| MounjaroTirzepatide | 11 | $17,103 |
| SynthroidLevothyroxine Sodium | 64 | $5,583 |
| Liothyronine Sodium | 75 | $3,089 |
| Levothyroxine Sodium | 62 | $709 |
| ProgesteroneProgesterone, Micronized | 16 | $537 |
| Metformin Hcl ErMetformin Hcl | 45 | $358 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $280 | $19,86722 claims |
| Lilly USA, LLCMounjaro | $94 | $17,10311 claims |
| AbbVieSynthroid | $59 | $5,58364 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $248 | $70962 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Mount Pleasant
- Tiffany DellingerMount Pleasant$9K
- Jenna DavisColumbia$202K
- David WiltGreenville$90K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
- Kellie McLainCharleston$28K
- Colleen BoydSummerville$21K
- Mae BurtonGreenville$21K
- Melissa BramanteColumbia$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.